Review: taking Adderall xr 15 and Zofran together


Summary

Drug interactions are reported among people who take Adderall xr 15 and Zofran together. This review analyzes the effectiveness and drug interactions between Adderall xr 15 and Zofran. It is created by eHealthMe based on reports of 195 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Adderall xr 15 and Zofran >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Adderall Xr 15

Adderall xr 15 has active ingredients of amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate. It is often used in attention deficit hyperactivity disorder. (latest outcomes from Adderall xr 15 244 users)

Zofran

Zofran has active ingredients of ondansetron hydrochloride. It is often used in nausea. (latest outcomes from Zofran 25,842 users)

On Aug, 20, 2016

195 people who take Adderall Xr 15, Zofran are studied.


Number of reports submitted per year:

Adderall xr 15 and Zofran drug interactions.

Drug effectiveness over time:

Adderall Xr 15:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 100.0% - (2 of 2 people)
  • 6 - 12 months: 80.0% - (4 of 5 people)
  • 1 - 2 years: 66.0% - (2 of 3 people)
  • 2 - 5 years: 80.0% - (4 of 5 people)
  • 5 - 10 years: 50.0% - (1 of 2 people)
  • 10+ years: 100.0% - (1 of 1 people)
  • not specified: 0.0% - (0 of 0 people)
Zofran:
  • < 1 month: 33.0% - (1 of 3 people)
  • 1 - 6 months: 50.0% - (2 of 4 people)
  • 6 - 12 months: 100.0% - (1 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 100.0% - (3 of 3 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 100.0% - (1 of 1 people)
  • not specified: 0.0% - (0 of 1 people)

Drug effectiveness by gender:

Adderall Xr 15:
  • female: 76.0% - (10 of 13 people)
  • male: 80.0% - (4 of 5 people)
Zofran:
  • female: 50.0% - (5 of 10 people)
  • male: 80.0% - (4 of 5 people)

Drug effectiveness by age:

Adderall Xr 15:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 100.0% - (1 of 1 people)
  • 20-29: 83.0% - (5 of 6 people)
  • 30-39: 80.0% - (4 of 5 people)
  • 40-49: 50.0% - (2 of 4 people)
  • 50-59: 100.0% - (1 of 1 people)
  • 60+: 100.0% - (1 of 1 people)
Zofran:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 1 people)
  • 20-29: 60.0% - (3 of 5 people)
  • 30-39: 100.0% - (4 of 4 people)
  • 40-49: 66.0% - (2 of 3 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 0.0% - (0 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • constipation
  • serotonin syndrome
  • dry mouth
  • fatigue
  • forgetfulness
  • impaired memory
  • lightheadedness - fainting
  • low blood pressure
  • mental status changes
  • mood swings
1 - 6 months:
  • abdominal pain
  • dehydration
  • foetal exposure during pregnancy
  • nausea
  • pneumothorax
  • vertigo
  • arnold-chiari malformation
  • chills
  • dizziness
  • fever
6 - 12 months:
  • colitis
  • constipation
  • esophageal spasm
  • esophageal stricture - benign
  • gastroparesis
  • migraine with aura
  • nausea and vomiting
  • skin disorder
  • acne
  • alopecia areata
1 - 2 years:
  • abdominal pain
  • arnold-chiari malformation
  • chills
  • dehydration
  • dizziness
  • fever
  • hallucination, visual
  • muscle pain
  • nausea
  • numbness and tingling
2 - 5 years:
  • cholecystitis chronic
  • fatigue
  • gallbladder disorder
  • pain
  • pancreatitis
  • sphincter of oddi dysfunction
  • stomach pain
  • forgetfulness
  • impaired memory
  • lightheadedness - fainting
5 - 10 years:
  • sweating increased
  • chest tightness or pressure
  • abscess - skin
  • anxiety
  • anxiety aggravated
  • back pain
  • bile duct stone
  • body temperature fluctuation
  • breath odor
  • breathing difficulty
10+ years:
  • central sleep apnea
not specified:
  • nausea
  • pain
  • abdominal pain
  • diarrhoea
  • pyrexia
  • anxiety
  • depression
  • dehydration
  • vomiting
  • fatigue

Most common drug interactions by gender *:

female:
  • nausea
  • pain
  • abdominal pain
  • cholecystitis chronic
  • dehydration
  • diarrhoea
  • fatigue
  • headache
  • constipation
  • gallbladder disorder
male:
  • anxiety
  • pyrexia
  • lung neoplasm
  • chronic sinusitis
  • rhinitis allergic
  • upper respiratory tract infection
  • depression
  • haematochezia
  • fall
  • pharyngitis

Most common drug interactions by age *:

0-1:
  • vomiting
  • weight decreased
  • accident
  • anaphylactoid reaction
  • arthritis
  • choking sensation
  • coma
  • drug hypersensitivity
  • dysgeusia
  • hepatic steatosis
2-9:
  • anxiety
  • attention deficit/hyperactivity disorder
  • b-cell lymphoma
  • chronic sinusitis
  • conjunctivitis
  • cough
  • depression
  • ear infection
  • eczema
  • eczema eyelids
10-19:
  • blood alkaline phosphatase increased
  • encephalopathy
  • haematochezia
  • hydrocephalus
  • hyperbilirubinaemia
  • hypoxia
  • meningitis bacterial
  • pleural effusion
  • respiratory distress
  • staphylococcal infection
20-29:
  • nausea
  • cholecystitis chronic
  • pain
  • abdominal pain
  • gallbladder disorder
  • dizziness
  • abdominal discomfort
  • anxiety
  • vomiting
  • pulmonary embolism
30-39:
  • constipation
  • abdominal pain
  • nausea
  • asthenia
  • intestinal obstruction
  • diarrhoea
  • gastrointestinal motility disorder
  • abdominal distension
  • abdominal pain lower
  • abdominal pain upper
40-49:
  • dehydration
  • diarrhoea
  • serotonin syndrome
  • fatigue
  • nausea
  • blood pressure fluctuation
  • mental status changes
  • pain
  • pyrexia
  • colitis
50-59:
  • injection site pain
  • abdominal pain
  • pain
  • abdominal pain upper
  • diarrhoea
  • drug ineffective
  • liver function test abnormal
  • nausea
  • sepsis
  • weight decreased
60+:
  • fatigue
  • myelitis transverse
  • nausea
  • oedema peripheral
  • rash
  • vomiting
  • anxiety
  • dehydration
  • depression
  • diarrhoea

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Adderall xr 15 and Zofran?

Can you answer these questions?

More questions for: Adderall xr 15, Zofran

You may be interested in these reviews

More reviews for: Adderall xr 15, Zofran

On eHealthMe, Adderall xr 15 (amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate) is often used to treat attention deficit hyperactivity disorder. Zofran (ondansetron hydrochloride) is often used to treat nausea. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.